Fluid management and deresuscitation practices - An opportunity for collaboration.
作者信息
Bissell Brittany D, Wieruszewski Patrick M, Newsome Andrea S, Verkerk Brittany S, Witenko Corey J, Ammar Mahmoud A, Magee Carolyn, Pajoumand Mehrnaz, Condeni Melanie Smith, Hammond Drayton A
机构信息
Department of Pulmonary, Critical Care, and Sleep Medicine, College of Medicine University of Kentucky, Lexington, KY, USA.
Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY,USA.
出版信息
J Intensive Care Soc. 2023 Nov;24(3 Suppl):24-26. doi: 10.1177/1751143720934386. Epub 2020 Jun 16.
Abstract
摘要
相似文献
1
Fluid management and deresuscitation practices - An opportunity for collaboration.液体管理与解除复苏措施——合作的契机
J Intensive Care Soc. 2023 Nov;24(3 Suppl):24-26. doi: 10.1177/1751143720934386. Epub 2020 Jun 16.
2
Fluid management and deresuscitation practices: A survey of critical care physicians.液体管理与复苏后处理措施：重症监护医师的一项调查
J Intensive Care Soc. 2020 May;21(2):111-118. doi: 10.1177/1751143719846442. Epub 2019 May 13.
3
Percent fluid overload for prediction of fluid de-escalation in critically ill patients in Saudi Arabia: a prospective observational study.沙特阿拉伯危重症患者中用于预测液体减量的液体超负荷百分比：一项前瞻性观察性研究。
Acute Crit Care. 2023 May;38(2):209-216. doi: 10.4266/acc.2022.01550. Epub 2023 May 16.
4
Effect of lung ultrasound-guided fluid deresuscitation on duration of ventilation in intensive care unit patients (CONFIDENCE): protocol for a multicentre randomised controlled trial.肺超声引导下液体复苏对 ICU 患者通气时间的影响（CONFIDENCE）：一项多中心随机对照试验方案。
Trials. 2023 Mar 24;24(1):226. doi: 10.1186/s13063-023-07171-w.
5
Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation After Resuscitation-2 (RADAR-2) randomised clinical trial.在危重病中与常规治疗相比，保守液体管理和去复苏的可行性：复苏后主动去复苏-2（RADAR-2）随机临床试验。
Intensive Care Med. 2022 Feb;48(2):190-200. doi: 10.1007/s00134-021-06596-8. Epub 2021 Dec 16.
6
Perfusion-based deresuscitation during continuous renal replacement therapy: A before-after pilot study (The early dry Cohort).基于灌注的连续肾脏替代治疗中再复灌：一项前后对照的初步研究（早期干燥队列）。
J Crit Care. 2022 Dec;72:154169. doi: 10.1016/j.jcrc.2022.154169. Epub 2022 Oct 3.
7
Correction: Feasibility of conservative fluid administration and deresuscitation compared with usual care in critical illness: the Role of Active Deresuscitation Correction: After Resuscitation-2 (RADAR-2) randomised clinical trial.更正：与危重症常规治疗相比，保守液体管理和复苏后降阶梯治疗的可行性：复苏后主动降阶梯治疗2（RADAR-2）随机临床试验。
Intensive Care Med. 2023 Nov;49(11):1440. doi: 10.1007/s00134-023-07174-w.
8
Deresuscitation in Patients with Abdominal Sepsis Carries a Lower Mortality Rate and Less Organ Dysfunction than Conservative Fluid Management.与保守液体管理相比，腹部脓毒症患者的复苏治疗死亡率更低，器官功能障碍更少。
Surg Infect (Larchmt). 2021 Apr;22(3):340-346. doi: 10.1089/sur.2019.370. Epub 2020 Aug 3.
9
Deresuscitation of Patients With Iatrogenic Fluid Overload Is Associated With Reduced Mortality in Critical Illness.医源性液体超负荷患者的复苏与危重病患者死亡率的降低有关。
Crit Care Med. 2018 Oct;46(10):1600-1607. doi: 10.1097/CCM.0000000000003276.
10
Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis.严重疾病复苏阶段后脓毒症或急性呼吸窘迫综合征患者的保守液体管理或再复苏：系统评价和荟萃分析。
Intensive Care Med. 2017 Feb;43(2):155-170. doi: 10.1007/s00134-016-4573-3. Epub 2016 Oct 12.
本文引用的文献
1
Fluid management and deresuscitation practices: A survey of critical care physicians.液体管理与复苏后处理措施：重症监护医师的一项调查
J Intensive Care Soc. 2020 May;21(2):111-118. doi: 10.1177/1751143719846442. Epub 2019 May 13.
2
Pharmacodynamics of intravenous frusemide bolus in critically ill patients.危重症患者静脉注射速尿推注的药效学
Crit Care Resusc. 2017 Jun;19(2):142-149.
3
Impact of a pharmacist-driven warfarin management protocol on achieving therapeutic International Normalized Ratios.由药剂师主导的华法林管理方案对实现治疗性国际标准化比值的影响。
Am J Health Syst Pharm. 2016 Mar 1;73(5 Suppl 1):S69-73. doi: 10.2146/sp150039.
4
Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services.关于重症监护药学服务的立场文件。危重病医学会和美国临床药学院重症监护药学服务特别工作组。
Crit Care Med. 2000 Nov;28(11):3746-50. doi: 10.1097/00003246-200011000-00037.
Zotero 插件